Bluechiip (BCT.AX) Stock Price
Bluechiip Price
Revenue has compounded at 30.4% per year over the past 12 years to 484,700.00 AUD. Bluechiip's net margin stands at -1,199.3%, up from -1,910.5% several years earlier.
Bluechiip stock price
Bluechiip business model & stock analysis
Frequently asked questions about Bluechiip
Bluechiip Ltd is an innovative technology company specializing in advanced tracking solutions. Founded in 2005, Bluechiip has revolutionized the way temperature-sensitive assets are monitored and tracked. The company's breakthrough technology combines both passive RFID and MEMS technologies to provide highly accurate and reliable identification of assets in extreme conditions. Bluechiip's patented product, the Bluechiip Smart, is leading the industry in healthcare, life sciences, and sample tracking. With a strong focus on innovation and continuous improvement, Bluechiip Ltd is committed to delivering cutting-edge tracking solutions to meet the evolving needs of its customers.
The business model of Bluechiip Ltd revolves around providing innovative tracking solutions for various industries. The company specializes in developing and commercializing advanced tracking technologies using its proprietary chip and software platform. Bluechiip's unique microchips enable real-time and robust tracking of valuable assets, such as biological samples, electronic components, and medical devices. By incorporating wireless communication and temperature sensing capabilities, Bluechiip's tracking solutions offer accurate monitoring and improved efficiency in inventory management. The company's technology finds applications in healthcare, pharmaceuticals, cryogenic storage, and logistics sectors, ensuring traceability and enhancing supply chain management. Bluechiip Ltd aims to deliver reliable and secure tracking solutions to facilitate seamless operations and safeguard valuable assets for its clients.
Bluechiip Ltd is primarily active in the healthcare and life sciences industries.
The main competitors of Bluechiip Ltd in the market include companies like Zymergen Inc., NanoString Technologies Inc., and Fluidigm Corporation.
Bluechiip Ltd has achieved several significant milestones. The company successfully developed its innovative wireless tracking solution, which combines a unique microchip with a passive RFID tag. Bluechiip's technology aims to revolutionize the storage and monitoring of critical biological samples, such as those used in healthcare and pharmaceutical industries. The company has also formed strategic partnerships with leading organizations in various sectors, including healthcare and biobanking, to showcase the potential of its solution. Bluechiip continues to enhance its product portfolio and expand its market reach, positioning itself as a key player in the field of advanced tracking and monitoring systems.
Bluechiip Ltd is primarily present in Australia.
Bluechiip Ltd represents values of innovation, reliability, and sustainability in its corporate philosophy. The company focuses on developing and commercializing advanced tracking solutions using its unique and patented technology. Bluechiip's solution provides a highly reliable, tamper-proof, and cost-effective method for tracking and monitoring critical samples, such as those used in healthcare, research, and logistics industries. With a commitment to continuous improvement and a customer-centric approach, Bluechiip aims to provide exceptional solutions that improve efficiency, reduce errors, and enhance overall operational effectiveness. As a result, Bluechiip Ltd sets itself apart as a leading provider of cutting-edge tracking technology solutions.
The Bluechiip share (BCT.AX) is listed on 2 stock exchanges, including: ASX (BCT.AX), Frankfurt (1BL.F).
Bluechiip Ltd is a leading provider of innovative solutions in the cryo-biology industry. The company specializes in developing sample management systems based on the unique Bluechiip technology to improve efficiency and accuracy in cryo-biology. The Bluechiip technology combines RFID and MEMS technology to identify samples even under extreme conditions of -196 degrees Celsius. It offers various products and solutions tailored to the needs of customers, including a sample management system with automatic sample tracking and real-time data monitoring. Bluechiip also partners with other companies in the cryo-biology industry to expand its product portfolio and develop new applications. The company invests in research and development to improve its product portfolio and develop new technologies. It focuses on markets such as biobanks, research institutions, cell therapy, clinical trials, and bioproduction and supply chain management. The Bluechiip technology provides enhanced data capture, increased security, and more efficient sample management solutions for the cryo-biology industry.
The expected revenue of Bluechiip is 8.29 M AUD. This figure is based on current financial data and reflects the company's business performance.
The profit cannot currently be calculated for Bluechiip.
The P/E ratio cannot be calculated for Bluechiip at the moment.
The P/S cannot be calculated for Bluechiip currently.
The Eulerpool Quality Score for Bluechiip is 4/10.
The ISIN of Bluechiip is AU000000BCT7. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The WKN of Bluechiip is A1JFYH. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.
The ticker of Bluechiip is BCT.AX. The ticker symbol is used to trade Bluechiip shares on the stock exchange.
Bluechiip stock
All fundamentals and in-depth analysis of Bluechiip
Our stock analysis for Bluechiip stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Bluechiip. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.